| Financial Highlights | Financial Review | | Management’s Report | Audit Committee’s Report | | Independent Auditors’ Report | Financial Statements | | Notes to Financial Statements | | Directors, Committees, and Officers | | Corporate and Shareholder Information |

	Audit Committee’s Report
	The Board of Directors reviews the audit function, internal controls and financial statements largely through its Audit Committee, which consists solely of directors who are not Company employees. In 1997, the Audit Committee met six times with management, the independent auditors and internal auditors concerning their respective responsibilities. Among its various duties, the Audit Committee recommends the appointment of the Company’s independent auditors. Both KPMG Peat Marwick LLP and the internal auditors have full access to the Audit Committee and meet with it, without management present, to discuss the scope and results of their examinations including internal control, audit and financial reporting matters. S. O. Ikenberry, Ph.D., Chair, Audit Committee February 26, 1998

	Advisory Information for Investors
	Copyright © 1997, 1998 Pfizer Inc All rights reserved.